Status:
COMPLETED
Attitudes and Decision Regret Regarding Fertility Preservation in Transgender Individuals
Lead Sponsor:
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions:
Fertility Preservation in Transgender Persons
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational survey is to learn how transgender adults think and feel about saving their fertility before gender-affirming treatment. We will ask at least 300 participants in Emilia-...
Detailed Description
Background \& Rationale For transgender individuals, fertility is particularly complex because gender-affirming treatments such as hormone therapy, hysterectomy, or orchiectomy can permanently impact...
Eligibility Criteria
Inclusion
- Self-identified as transgender
- Age ≥ 18 years.
Exclusion
- None
Key Trial Info
Start Date :
March 29 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2025
Estimated Enrollment :
616 Patients enrolled
Trial Details
Trial ID
NCT07194226
Start Date
March 29 2025
End Date
May 31 2025
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, BO, Italy, 40138